TransMedics Group, Inc.
TMDX • NASDAQ
TransMedics Group, Inc. is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Waleed H. Hassanein, with a market cap of $3.4B.
CEOWaleed H. Hassanein
Next Earnings
Upcoming earnings announcement for TransMedics Group, Inc.
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.62
Revenue Estimate
$174.7M
Earnings History
Past 12 earnings reports for TransMedics Group, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 24, 2026 | Q4 2025 | $0.57Est: $0.39 | +46.2% | $160.8MEst: $155.3M | +3.5% |  10-K |
| Oct 29, 2025 | Q3 2025 | $0.66Est: $0.36 | +83.3% | $143.8MEst: $144.8M | -0.7% | 10-Q |
| Jul 30, 2025 | Q2 2025 | $0.92Est: $0.45 | +104.4% | $157.4MEst: $147.6M | +6.6% | 10-Q |
| May 8, 2025 | Q1 2025 | $0.70Est: $0.24 | +191.7% | $143.5MEst: $123.4M | +16.3% | 10-Q |
| Feb 27, 2025 | Q4 2024 | $0.19Est: $0.16 | +18.8% | $121.6MEst: $110.3M | +10.3% | 10-K |
| Oct 28, 2024 | Q3 2024 | $0.12Est: $0.30 | -60.0% | $108.8MEst: $115.0M | -5.4% | 10-Q |
| Jul 31, 2024 | Q2 2024 | $0.35Est: $0.21 | +66.7% | $114.3MEst: $99.0M | +15.5% | 10-Q |
| Apr 30, 2024 | Q1 2024 | $0.35Est: -$0.05 | +800.0% | $96.9MEst: $83.8M | +15.6% | 10-Q |
| Feb 26, 2024 | Q4 2023 | $0.12Est: -$0.03 | +500.0% | $81.2MEst: $68.5M | +18.5% | 10-K |
| Nov 6, 2023 | Q3 2023 | $0.12Est: -$0.16 | +175.0% | $66.4MEst: $49.2M | +35.1% | — |
| Aug 3, 2023 | Q2 2023 | -$0.03Est: -$0.13 | +76.9% | $52.5MEst: $42.4M | +23.7% | 10-Q |
| May 1, 2023 | Q1 2023 | -$0.08Est: -$0.25 | +68.0% | $41.6MEst: $36.1M | +15.3% | — |